TORONTO, ONTARIO, Nov. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTCPK:BLFE) announces it has initiated the process of up-listing to the Over the Counter Quotation Bureau ...
BioLife shareholders will receive $11.25 in cash and 0.1442 shares of Repligen for each share, valuing the cell therapy tools supplier at $31 per share — a premium of about 6.2% to BioLife's last ...
Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Plasma donation and testing company BioLife Plasma Services LP in has invested $4 million to expand its testing laboratory in Hoover, Ala., and buy equipment to recycle biohazardous plastics waste ...
New centers will open in Southern California to support an urgent need for plasma donations used to develop therapies for people with a variety of rare diseases MORENO VALLEY, Calif.--(BUSINESS WIRE)- ...
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc. - BLFS Former Attorney General of Louisiana Charles C.
For decades, people seeking regenerative therapies, hormone treatments, or advanced wellness solutions have had to navigate a fragmented system. One physician might offer hormone replacement, another ...
TUKWILA, Wash.--(BUSINESS WIRE)--BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma ...
July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal valued at about $1.5 billion, to expand the drugmaking equipment provider's presence in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results